Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by palinc2000on Mar 27, 2024 5:27pm
61 Views
Post# 35956631

RE:RE:RE:RE:RE:RE:RE:Voting for AGM

RE:RE:RE:RE:RE:RE:RE:Voting for AGMTHTX BOD  and management have  shown very little out of the box thinking .Reactive management vs pro active management.
When Levesque was hired I wrote that there was a new sherif in town after his first speech when he mentioned keeping people accountable  and conducting a deep dive in the pipeline and everything in the organization,
I was expecting a change of CFO but nothing happened .I wrote that not firing Dubuc would bring Paul s demise ....I quoted the Chinese proverb that A NEW BROON SPEEPS CLEAN...
LEVESQUE DID NOTHING ...HE joined into  in a sick Company and he made it sicker ,,,,He should be fired for cause but he wont ......
A SHERIFF with a toy gun ....big talk no action ....I rate him a big  zero out of 10 with regards to my expectations ...Walking a fine line between   legal transparency and legal opacity.......

I welcome any comments from investors not agreeing with me ....
For me it is not about the Share Price .....I am a grown man!!!! It is about how we got to the SP ,,,,,,,
and the BOD  lack of Fiduciary Responsibility in not taking steps to hold management accountable 

WELCOME JORDAN SWICK,,,,,,,!!!!
 


palinc2000 wrote: I dont know what their exit point would be acceptable ......Do they still have hope for the oncology platform? Do they think that THTX"s approach to increasing sales of their products is the right one?
What do they think of Tesamorelin "s best course in Nash?
ALL I KNOW IS THAT THEY FEEL STRONGLY THAT THEIR EXIT PRICE IS HIGHER THAN TODAY'S


juniper88 wrote: I have similar thoughts.  

Any thoughts on what might be an acceptable share price for Soleus?  Based on how much they got in for.

Like you I bought quite a few shares when this went down to $1.30 Canadian.  

palinc2000 wrote: Zwick'S has one mission.....Put some lipstick on the Company and get the Company ready for a takeover to minimize Soleus 's loss

I am now 100% positive that he is Soleus nominee and consequently getting compensated by Soleus and maybe with an additional incentive to share in the rise of the SP

Dawn and Paul and Dubuc need to go asap for the Plan to work 


juniper88 wrote:
PWIB123 and Manequin I am on the same page with both of you on this.

One thing I have to wonder about.  Why would someone with Zwick's seemingly considerable talent and experience possibly touch the like of Thera with a ten feet pole, let alone become a board member?

Any thoughts? 
 
PWIB123 wrote: It doesn't even matter to me if they show efficacy or have good results from TH-1902.  They've had too many blunders, too many mistakes, and have proven they are incapable of communicating properly or driving shareholder value.  I'm voting against every one of them except Zwick on the premise that they have yet to demonstrate any sense of proper leadership.  They may have protected themselves, but I'm still going to vote against them.

Trogarzon wrote: Again I will vote my shares against ALL execpt the new guy Zwick.  Also, I will ask everyone I know to vote their shares this year once again.  Unless they have really good efficacity in part 3 of P1 th1902 and it's not designed for that well they will be voted OUT.




PWIB123








<< Previous
Bullboard Posts
Next >>